| 相似文献(共20条): | | [1]、 | Nguyen-Pham TN,Im CM,Nguyen TA,Lim MS,Hong CY,Kim MH,Lee HJ,Lee YK,Cho D,Ahn JS,Yang DH,Kim YK,Chung IJ,Kim HJ,Lee JJ.Induction of myeloma-specific cytotoxic T lymphocytes responses by natural killer cells stimulated-dendritic cells in patients with multiple myeloma[J].Leukemia research,2011,35(9):1241-1247. | | [2]、 | Godfrey J,Benson DM.The role of natural killer cells in immunity against multiple myeloma[J].Leukemia & lymphoma,2012,53(9):1666-1676. | | [3]、 | T Funato,A Koide,H Ohtani,M Saito.Studies on the mechanism of defective natural killer cytotoxicity in patients with multiple myeloma[J].Gan no rinsho,1984,30(4):368-372. | | [4]、 | H M Ogmundsdóttir.Natural killer cell activity in patients with multiple myeloma[J].Cancer Detection and Prevention,1988,12(1-6):133-143. | | [5]、 | Y Kataoka,S Todo,Y Morioka,K Sugie,Y Nakamura,J Yodoi,S Imashuku.Impaired natural killer activity and expression of interleukin-2 receptor antigen in familial erythrophagocytic lymphohistiocytosis[J].Cancer,1990,65(9):1937-1941. | | [6]、 | Tsimanis A,Shtalrid M,Shvidel L,Kalinkovich A,Berrebi A,Klepfish A.Expression of interleukin-11 receptor in CD38-positive cells from patients with multiple myeloma[J].Leukemia & lymphoma,2004,45(11):2315-2319. | | [7]、 | Kawamata A,Ito D,Odani T,Isobe T,Iwase M,Hatori M,Nagumo M.Thalidomide suppresses melanoma growth by activating natural killer cells in mice[J].Oncology reports,2006,16(6):1231-1236. | | [8]、 | 王秀菊,尹松梅,马丽萍,李益清,聂大年,谢双峰,肖洁.骨髓瘤RPMI 8226细胞体外逃逸NK细胞免疫杀伤机制的初步研究[J].中华肿瘤防治杂志,2011,18(17). | | [9]、 | Lu X,Zhu A,Cai X,Jia Z,Han W,Ma L,Zhou M,Qian K,Cen L,Chen B.Role of NKG2D in cytokine-induced killer cells against multiple myeloma cells[J].Cancer biology & therapy,2012,13(8):623-629. | | [10]、 | Transfection of chimeric anti-CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells[J].Molecular oncology | | [11]、 | José A Campillo,Jorge A Martínez-Escribano,M Rosa Moya-Quiles,Luis A Marín,Manuel Muro,Natalia Guerra,Antonio Parrado,Matilde Campos,José F Frías,Alfredo Minguela,Ana M García-Alonso,María Rocío Alvarez-López.Natural killer receptors on CD8 T cells and natural killer cells from different HLA-C phenotypes in melanoma patients.[J].Clinical cancer research,2006,12(16):4822-4831. | | [12]、 | A V LeFever,A Funahashi.Phenotype and function of natural killer cells in patients with bronchogenic carcinoma.[J].Cancer research,1991,51(20):5596-5601. | | [13]、 | S Einhorn,A Ahre,H Blomgren,B Johansson,H Mellstedt,H Strander.Interferon and natural killer activity in multiple myeloma. Lack of correlation between interferon-induced enhancement of natural killer activity and clinical response to human interferon-alpha[J].International journal of cancer. Journal international du cancer,1982,30(2):167-172. | | [14]、 | I P Law,J Blom.Second malignancies in patients with multiple myeloma.[J].Oncology,1977,34(1):20-24. | | [15]、 | Pietra G,Manzini C,Rivara S,Vitale M,Cantoni C,Petretto A,Balsamo M,Conte R,Benelli R,Minghelli S,Solari N,Gualco M,Queirolo P,Moretta L,Mingari MC.Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity[J].Cancer research,2012,72(6):1407-1415. | | [16]、 | H Mellstedt.Treatment of multiple myeloma with natural alpha-interferon[J].Hematological oncology,1988,6(2):187-192. | | [17]、 | Dysfunction of natural killer cells in patients with transitional cell carcinoma[J].Cancer letters | | [18]、 | Kitajima M,Ito T,Tumes DJ,Endo Y,Onodera A,Hashimoto K,Motohashi S,Yamashita M,Nishimura T,Ziegler SF,Nakayama T.Memory type 2 helper T cells induce long-lasting antitumor immunity by activating natural killer cells[J].Cancer research,2011,71(14):4790-4798. | | [19]、 | 何祎,周征,王荷花,王玫,黄勇,刘庆国,姜尔烈,周世勇,王志东,翟文静,冯四洲,韩明哲.抑制性杀伤细胞受体在NK细胞和T细胞上的表达及其与急性移植物抗宿主病的关系[J].白血病．淋巴瘤,2007,16(2):88-90. | | [20]、 | Hiroaki Saito,Seigo Takaya,Tomohiro Osaki,Masahide Ikeguchi.Increased apoptosis and elevated Fas expression in circulating natural killer cells in gastric cancer patients[J].Gastric cancer,2013,16(4):473-479. |
|
